| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 292,700 | 288,100 | 264,400 | 333,200 | | Cost of Revenue | 287,600 | 126,300 | 95,900 | 539,000 | | | Gross Profit | 5,100 | 161,800 | 168,500 | (205,800) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 57,200 | 30,700 | 36,400 | (339,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | (119,300) | 68,200 | 51,100 | 52,200 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 67,200 | 62,900 | 81,000 | 81,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 67,200 | 62,900 | 81,000 | 81,000 | | Interest Expense | 40,300 | 43,200 | 41,500 | 40,700 | | Income Before Tax | 26,900 | 19,700 | 39,500 | 40,300 | | Income Tax Expense | 7,300 | 7,000 | 11,900 | 11,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 19,600 | 12,700 | 27,600 | 28,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,600 | 12,700 | 27,600 | 28,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $19,600 | $12,700 | $27,600 | $28,900 |
|
0.88% Nasdaq 
Income Statement
